RTI Surgical (RTIX) 10-Q2009 Q1 Quarterly report

Filed: 1 May 09, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: anticipated, appealed, ARB, bad, challenging, Code, commencing, consulting, contingency, conversion, delay, demand, ENT, fascia, forfeited, French, grow, Health, inflationary, intellectual, lata, launch, launching, LifeNet, located, MDT, monetary, multiplied, obsolescence, pericardium, qualify, rent, sclera, sourcing, surrendered, travel, ultimately, VAT, whichever

Removed: Accelerated, accounted, accuracy, acquiree, adjusted, administration, allocated, allocation, amortizable, application, applying, approved, assembled, assessed, Balanced, begin, breach, capitalize, capitalized, certificate, charged, choose, collateralized, combination, combined, commissioned, comparative, compliance, concentration, converted, core, corporate, corporation, covenant, cryolife, Danek, data, deductible, Delaware, deposit, determining, discount, discounted, disposed, Diversification, dividend, dividing, documentation, donated, Drug, EITF, eligible, enabling, evaluating, exchanged, exit, finalized, Food, forma, fourth, fracture, growth, guaranteed, guidance, impacted, implant, impossible, incur, individual, initiated, integrate, intend, jaw, joint, June, leasehold, lender, machinery, maintenance, marketable, maximum, measure, measurement, model, monthly, move, MSD, negative, noncancelable, occurred, October, operational, Overview, parent, passed, periodic, preliminary, preparing, primary, procuring, range, ratio, realize, reduced, reducing, reflected, relation, relationship, renew, rental, replace, representative, requirement, responsible, restocking, retired, RTIB, sale, scientific, secure, selling, senior, sheet, single, Sofamor, sterile, sterilized, stockholder, subsequent, substantial, substantially, substitute, successful, supplier, tangible, team, translate, transmit, treated, underlying, unrestricted, updated, utilized, variable, variety, vertebrae, vested, volatility, volume, voluntary, warranty, weighted, wide, worth, yield

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

RTIX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of RTI Biologics, Inc. (the "Company") on Form 10-Q for the quarter ended March 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Thomas F. Rose, Vice President, Chief Financial Officer and Secretary of the Company, hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Thomas F. Rose				Dated: May 1, 2009
Thomas F. Rose
Executive Vice President, Chief Financial Officer and Secretary

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of this Report or as a separate disclosure document. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.